Evaluation of poly(d,l-lactide-co-glycolide) microspheres for the lung-targeting of yuanhuacine, a novel DNA topoisomerase i inhibitor Lung-targeting evaluation of PLGA microspheres loaded with YHC S. Zhang et al.

Journal of Drug Targeting

Volumn 17, Issue 4, 2009, Pages 286-293

  Zhang, Shixuan ^a   Gao, Xiujuan ^a   Shen, Kaihua ^a   Yang, Puwen ^a   Ju, Xiulan ^b  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b DALIAN UNIVERSITY   (China)

Author keywords

Anticancer; Fluorescent spiropyran labeled; Lung targeting; PLGA microspheres; Yuanhuacine

Indexed keywords

DNA TOPOISOMERASE INHIBITOR; DYE; MICROSPHERE; POLYGLACTIN; SPIROPYRAN; UNCLASSIFIED DRUG; YUANHUACINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG DISTRIBUTION; DRUG RELEASE; DRUG SCREENING; DRUG STRUCTURE; DRUG TARGETING; FEMALE; FLUORESCENCE MICROSCOPY; GLASS TRANSITION TEMPERATURE; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; LUNG EMBOLISM; MALE; MICROTOME; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RABBIT;

ANIMALS; DITERPENES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENZYME INHIBITORS; FEMALE; INJECTIONS, INTRAVENOUS; LACTIC ACID; LUNG; MALE; MICE; MICROSCOPY, FLUORESCENCE; MICROSPHERES; MICROTOMY; PARTICLE SIZE; POLYGLYCOLIC ACID; RABBITS; TISSUE DISTRIBUTION; TOPOISOMERASE I INHIBITORS; TRANSITION TEMPERATURE;

EID: 69649090303     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860902737912     Document Type: Article

References (21)

1. Anderson JM, Shive MS. (1997). Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev, 28, 5-23.
2. Berkovic G, Krongauz V, Weiss V. (2000). Spiropyrans and spirooxazines for memories and switches. Chem Rev, 100, 1741-1753.
3. Chen L, Apte RN, Cohen S. (1997). Characterization of PLGA microspheres for the controlled delivery of IL-1? for tumor immunotherapy. J Control Release, 43, 261-272.
4. Davis SS, Hunneyball IM, Illum L, Ratcliffe JH, Smith A, Wilson CG. (1985). Recent advances in the use of microspheres for targeted therapy. Drugs Exp Clin Res, 11, 633-640.
5. Gabor F, Ertl B, Wirth M, Mallinger R. (1999). Ketoprofen-poly (d,llactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics. J Microencapsulation, 16, 1-12.
6. Hall IH, Kasai R, Wu RY, Wu K, Tagahara Lee KH. (1982). Antitumor agents IV: Effects of genkwadaphnin and YHC on nucleic acid synthesis of P-388 lymphocytic leukemia cells. Pharm Sci, 71, 1263-1267.
7. Hall IH, Liou YF, Qswald CB, Lee KH. (1986). The effects of genkwadaphnin and gnidilatidin on the growth of P-388, L-1210leukemia and KB carcinoma cells in vitro. Eur J Cancer Clin Oncol, 22, 45-52.
8. Huo DJ, Deng SH, Li LB, Ji J. (2005). Studies on the poly(lactic- coglycolic) acid microspheres of cisplatin for lung targeting. Int J Pharm, 289, 63-67.
9. Koelsch CF, Workman WR. (1952). Some thermochromic spirans. J Am Chem Soc, 74, 6288-6289.
10. Liou YF, Hall IH, Lee KH. (1982). Antitumor agents LVI: The protein synthesis inhibition by genkwadaphnin and yuanhuacine of P-388 lymphocytic leukemia cells. Pharm Sci, 71, 1340-1344.
11. Lu B, Zhang JQ, Yang H. (2003). Lung-targeting microspheres of carboplatin. Int J Pharm, 265, 1-11.
12. Park BY, Min BS, Ahn KS, Kwon OK, Joung H, Bae KH, Lee HK, Oh SR. (2007). Daphnane diterpene esters isolated from flower buds of Daphne genkwa induce apoptosis in human myelocytic HL-60 cells and suppress tumor growth in Lewis lung carcinoma (LLC)- inoculated mouse model. J Ethnopharmacol, 111, 496-503.
13. Park TG. (1995). Degradation of poly(lactic-co-glycolic acid) microspheres: Effect of copolymer composition. Biomaterials, 16, 1123-1130.
14. Sandor M, Harris J, Mathiowitz E. (2002). A novel polyethylene depot device for the study of PLGA and P(FASA) microspheres in vitro and in vivo. Biomaterials, 23, 4413-4423.
15. Tracy MA, Ward KL, Firouzabadian L, Wang Y, Dong N, Qian R, Zhang Y. (1999). Factors affecting the degradation rate of poly (lactide-co-glycolide) microspheres in vivo and in vitro. Biomaterials, 20, 1057-1062.
16. Waeckerle-Men Y, Allmen EU, Gander B, Scandella E, Schlosser E, Schmidtke G, Merkle HP, Groettrup M. (2006). Encapsulation of proteins and peptides into biodegradable poly (d,l-lactide- co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells. Vaccine, 24, 1847-1857.
17. Wang YM, Sato H, Horikoshi I. (1997). In vitro and in vivo evaluation of taxol release from poly (lactic-co-glycolic acid) microspheres containing isopropyl myristate and degradation of the microspheres. J Control Release, 49, 157-166.
18. Wang YW, Sato H, Adachi I, Horikoshi I. (1996). Preparation and characterization of poly(lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent, taxol. Chem Pharm Bull, 44, 1935-1940.
19. Zhan ZJ, Fan CQ, Ding J, Yue JM. (2005). Novel diterpenoids with potent inhibitory activity against endothelium cell HMEC and cytotoxic activities from a well-known TCM plant Daphne genkwa. Bioorg Med Chem, 13, 645-655.
20. Zhang SX, Li XN, Zhang FH, Yang PW, Gao XJ, Song QL. (2006). Preparation of yuanhuacine and relative daphne diterpene esters from Daphne genkwa and structure-activity relationship of potent inhibitory activity against DNA topoisomerase I. Bioorg Med Chem, 14, 3888-3895.
21. Zhang SX, Zhang FH, Li XN, Wen LH, Wang SS. (2007). Fingerprint of daphne diterpene esters from Daphne genkwa by high-performance liquid chromatography and quantitative analysis and anticancer activity of yuanhuacine. Phytochem Anal, 18, 91-97.